高龄高危前列腺增生患者经尿道钬激光前列腺剜除术50例分析  

Application of transurethral holmium laser enucleation of the prostate to the aging patients: 50 cases report

作　　者：付光[1] 廖利民[1] 鞠彦合[1] 李东[1] 韩春生[1] 熊宗胜[1] 史文博[1] 吴娟[1] 黄悦[1] 

机构地区：[1]北京博爱医院泌尿外科,北京市100068

出　　处：《中国康复理论与实践》2005年第11期910-911,共2页Chinese Journal of Rehabilitation Theory and Practice

摘　　要：目的探讨经尿道钬激光前列腺剜除术治疗良性前列腺增生的安全性和临床疗效。方法50例年龄超过70岁的高龄前列腺增生患者接受经尿道钬激光前列腺剜除术,术前及术后3个月进行国际前列腺症状评分(IPSS)、生活质量评分(QOL)、最大尿流率(Qmax)、残余尿量(PVR)的测定。结果术前患者平均IPSS 29.9,QOL 5.3、Qmax7.2 ml/s、PVR 127.5 ml,术后3个月平均分别为9.7、1.9、16.3 ml/s、19.3 ml,均有显著性差异(P<0.05)。结论经尿道钬激光前列腺剜除术是一项安全、高效的治疗良性前列腺增生的新方法。Objective To investigate the safety and efficiency of transurethral holmium laser enucleation of the prostate（Ho-LEP） for the aged. Methods 50 old patients （above 70） with benign prostatic hyperplasia （BPH） accepted HoLEP. All patients were assessed with IPSS, QOL, Qmax and PVR before and 3 months after operation. Results Before the treatment, the mean IPSS was 22.9 and was 9.7 3 months after operation, while the mean QOL was 5.3 and 2.1, Qmax was 7.2 ml/s and 14.3 ml/s, PVR was 127.5 ml and 19.3 ml. Conclusion HoLEP is a safe, effective procedures for treating BPH.

关 键 词：良性前列腺增生 钬激光 老年 前列腺剜除术 

分 类 号：R697.3[医药卫生—泌尿科学]